C07D 215/50
Attached in position 4
Official title: attached in position 4
C07D215/50 (Attached in position 4) appears on 265 US grants and 256 published applications in this corpus.
Search patents in C07D- Granted patents
- 265
- Published applications
- 256
- Assignees
- 172
- Inventors
- 926
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 7 | 0 |
| 1993 | 4 | 0 |
| 1994 | 9 | 0 |
| 1995 | 8 | 0 |
| 1996 | 11 | 0 |
| 1997 | 13 | 0 |
| 1998 | 19 | 0 |
| 1999 | 2 | 0 |
| 2000 | 9 | 0 |
| 2001 | 7 | 1 |
| 2002 | 9 | 12 |
| 2003 | 7 | 9 |
| 2004 | 8 | 25 |
| 2005 | 6 | 16 |
| 2006 | 10 | 17 |
| 2007 | 6 | 8 |
| 2008 | 2 | 20 |
| 2009 | 7 | 8 |
| 2010 | 2 | 11 |
| 2011 | 4 | 5 |
| 2012 | 6 | 8 |
| 2013 | 5 | 4 |
| 2014 | 6 | 13 |
| 2015 | 9 | 7 |
| 2016 | 2 | 7 |
| 2017 | 6 | 6 |
| 2018 | 6 | 6 |
| 2019 | 8 | 7 |
| 2020 | 3 | 8 |
| 2021 | 10 | 15 |
| 2022 | 6 | 9 |
| 2023 | 4 | 7 |
| 2024 | 7 | 12 |
| 2025 | 5 | 5 |
| 2026 | 4 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Tumor stroma imaging agent and preparation method thereof14 Apr 2026US 12,599,685 B2Shanghai University of Medicine & Health Sciences
- Tetrahydroquinoline derivative and medicinal use thereof10 Mar 2026US 12,570,639 B2Toray Industries, Inc.
- Nitroxoline derivative, preparation method therefor, and use thereof23 Dec 2025US 12,503,440 B2Asieris Pharmaceuticals (Shanghai) Co., Ltd.
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Quinolineimine antidegradant compounds and uses thereof24 Sep 2026US 2026/0285812 A1Flexsys IP Holdings, LLC
- Therapeutic compounds24 Sep 2026US 2026/0285836 A1Rutgers, The State University of New Jersey
- Pdk1 regulatory compound and composition containing the same2 Jul 2026US 2026/0183274 A1Provibio Co., Ltd.
- Pdk1 regulatory compound and composition containing the same2 Jul 2026US 2026/0183302 A1Provibio Co., Ltd.
Most cited
By later US patents
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase171US 5,646,153 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1997
- Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties144US 5,721,237 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998